Tasked with persuading shoppers at an outdoor market to consider taking the AstraZeneca COVID-19 vaccine, Paris city hall employee Leo Martin was finding it a tough sell.
“Which vaccine is it?” one woman, in a green scarf, asked when Martin approached her with his pitch inviting people to get inoculated at a neighborhood vaccination center.
When Martin told her the shot being offered at the center was manufactured by AstraZeneca, the woman in the green scarf shook her head and said: “No, I don’t want that.”
Across the European Union, opinion polls and data from government vaccination programs indicate a widespread skepticism about the AstraZeneca vaccine, rooted in very rare cases of people who take the shot experiencing blood clots.
In response to the blood-clotting cases, Denmark stopped administering the shot, and several other EU states including France are limiting it to older people.
The EU’s medicines watchdog says the benefits of taking the shot far outweigh any risks, and most EU governments encourage their citizens to take it if offered.
France is also administering vaccines produced by Pfizer and Moderna, but the batch Martin and his colleagues were offering was from AstraZeneca.
“There is definitely a reluctance with regards to AstraZeneca,” Martin said in a break from handing out vaccination leaflets at the market, in the north-eastern corner of Paris.
He tries to reassure people that the risks are tiny, he said, “but there’s not much we can do with people’s anxiety at this point”.
Nevertheless, there were takers. Among people showing up for jabs at the nearby center was Dabo Mamadou, 70.
“I try to convince those around me,” to take the vaccine, he said just after having the shot in his right shoulder.
But, he said, several people in his circle were reluctant to get the AstraZeneca shot because they had heard the news reports about the blood-clotting cases.
AstraZeneca could have COVID-19 vaccine against variant by end-2021: Austrian mediaA modified version of AstraZeneca’s COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the ... Coronavirus
Canada has second case of rare blood clots after AstraZeneca vaccineCanada on Saturday reported a second case of rare blood clots with low platelets after immunization with AstraZeneca's COVID-19 vaccine in a week, ... Coronavirus
AstraZeneca chief says committed to supply COVAX, calls for open bordersThe CEO of Astrazeneca Pascal Soriot said on Thursday that although the Anglo-Swedish company had hit “bumps on the road” it had been able to deliver ... Coronavirus
Ireland expects AstraZeneca restrictions to have ‘minimal’ impact on vaccine rolloutIrish authorities expect new restrictions on the use of AstraZeneca’s COVID-19 vaccine should have a “fairly minimal” impact on the country’s vaccine ... Coronavirus